{
    "code": "02015316",
    "許可證字號": "衛署藥輸字第015316號",
    "註銷狀態": "已註銷",
    "註銷日期": "81\/07\/01",
    "註銷理由": "有效期間已屆未能補件",
    "有效日期": "80\/07\/17",
    "發證日期": "75\/08\/18",
    "許可證種類": "製　劑",
    "舊證字號": "13005423",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201531602",
    "中文品名": "克利哮喘注射劑",
    "英文品名": "ASTHMOLYSIN",
    "適應症": "支氣管性氣喘",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "EPINEPHRINE HCL, POST PITUITARY EXTRACT",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1305619100  資生股份有限公司",
    "申請商地址": "台南巿忠義路２段１３４號",
    "主製造廠": {
        "製造廠名稱": "F470057000  DR. KADE PHARMAZEUTISCHE FABRIK GMBH",
        "製造廠廠址": "OPELSTRABE 2, 7750 CONSTANCE",
        "製造廠公司地址": "",
        "製造廠國別": "GERMANY",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1212000610",
            "成分名稱": "EPINEPHRINE HCL",
            "含量描述": "(0.1%),0.800",
            "含量": "",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "6828000401",
            "成分名稱": "POST PITUITARY EXTRACT",
            "含量描述": "0.010",
            "含量": "0.0100000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020153160001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02015316&Seq=001&Type=9"
        }
    ]
}